Skip to content
Catalyst

linoleic acidWhat was measured

Measured, with no finding

299 endpoints

Show what was measuredHide what was measured
  • All-cause mortality

    increases, p = 0.051

    an increased risk of all cause mortality (17.6% v 11.8%; hazard ratio 1.62 (95% confidence interval 1.00 to 2.64); P=0.051)

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.05, n = 207

    LA:SFA ratio (per 1 unit increase) | 1 | 1.51 (1.00 to 2.30) | 0.05 | 1.59 (1.04 to 2.43) | 0.03 | 1.44 (0.93 to 2.23) | 0.11

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.04, n = 207

    2 | 1.55 (1.01 to 2.36) | 0.04 | 1.62 (1.05 to 2.48) | 0.03 | 1.47 (0.94 to 2.29) | 0.09

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.05, n = 207

    PUFA (LA specific; per 5 en% increase) | 1 | 1.31 (1.00 to 1.71) | 0.05 | 1.37 (1.04 to 1.79) | 0.03 | 1.20 (0.90 to 1.59) | 0.22

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.05, n = 207

    2 | 1.29 (1.00 to 1.67) | 0.05 | 1.35 (1.03 to 1.75) | 0.03 | 1.21 (0.91 to 1.61) | 0.19

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.66, n = 222

    PUFA:SFA ratio (per 1 unit increase) | 1 | 0.84 (0.39 to 1.80) | 0.66 | 0.78 (0.36 to 1.70) | 0.53 | 0.56 (0.27 to 1.18) | 0.13

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.04, n = 429

    PUFA:SFA ratio (per 1 unit increase) | 1 | 1.35 (1.01 to 1.80) | 0.04 | 1.39 (1.03 to 1.87) | 0.03 | 1.27 (0.93 to 1.73) | 0.14

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.88, n = 222

    2 | 1.05 (0.56 to 1.97) | 0.88 | 1.00 (0.52 to 1.93) | 0.99 | 0.77 (0.39 to 1.52) | 0.46

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.01, n = 429

    2 | 1.53 (1.14 to 2.05) | <0.01 | 1.58 (1.17 to 2.13) | <0.01 | 1.44 (1.04 to 1.98) | 0.03

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.28, n = 222

    SFA (per 5 en% increase) | 1 | 0.77 (0.48 to 1.24) | 0.28 | 0.89 (0.54 to 1.47) | 0.65 | 0.98 (0.58 to 1.65) | 0.93

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.18, n = 207

    SFA (per 5 en% increase) | 1 | 0.77 (0.52 to 1.13) | 0.18 | 0.77 (0.52 to 1.13) | 0.18 | 0.74 (0.50 to 1.11) | 0.15

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    decreases, p = 0.03, n = 429

    SFA (per 5 en% increase) | 1 | 0.74 (0.57 to 0.97) | 0.03 | 0.77 (0.58 to 1.01) | 0.06 | 0.77 (0.58 to 1.03) | 0.08

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.25, n = 222

    2 | 0.76 (0.48 to 1.21) | 0.25 | 0.86 (0.53 to 1.39) | 0.54 | 0.95 (0.57 to 1.58) | 0.84

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.29, n = 207

    2 | 0.81 (0.56 to 1.19) | 0.29 | 0.82 (0.56 to 1.21) | 0.31 | 0.78 (0.52 to 1.16) | 0.22

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    decreases, p = 0.01, n = 429

    2 | 0.70 (0.53 to 0.91) | <0.01 | 0.72 (0.54 to 0.95) | 0.02 | 0.72 (0.54 to 0.97) | 0.03

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.71, n = 222

    PUFA (unspecified; per 5 en% increase) | 1 | 1.08 (0.71 to 1.66) | 0.71 | 1.07 (0.69 to 1.67) | 0.75 | 1.00 (0.62 to 1.61) | 0.99

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.02, n = 429

    PUFA (unspecified; per 5 en% increase) | 1 | 1.26 (1.04 to 1.52) | 0.02 | 1.29 (1.07 to 1.57) | <0.01 | 1.19 (0.97 to 1.47) | 0.09

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    no effect, p = 0.65, n = 222

    2 | 1.10 (0.73 to 1.65) | 0.65 | 1.09 (0.72 to 1.66) | 0.68 | 1.02(0.65 to 1.60) | 0.93

    PMID 23386268 · one of two readings recorded this

  • All-cause mortality

    increases, p = 0.01, n = 429

    2 | 1.31 (1.09 to 1.58) | <0.01 | 1.35 (1.12 to 1.63) | <0.01 | 1.26 (1.02 to 1.54) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Body mass index

    no effect, p = 0.26

    Body mass index | 25.4 (25.1 to 25.8) | 25.1 (24.8 to 25.3) | 24.5 (24.1 to 24.9) | 24.3 (24.0 to 24.6) | 0.26

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.037

    cardiovascular mortality (17.2% v 11.0%; 1.70 (1.03 to 2.80); P=0.037)

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.03, n = 207

    LA:SFA ratio (per 1 unit increase) | 1 | 1.51 (1.00 to 2.30) | 0.05 | 1.59 (1.04 to 2.43) | 0.03 | 1.44 (0.93 to 2.23) | 0.11

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.03, n = 207

    2 | 1.55 (1.01 to 2.36) | 0.04 | 1.62 (1.05 to 2.48) | 0.03 | 1.47 (0.94 to 2.29) | 0.09

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.03, n = 207

    PUFA (LA specific; per 5 en% increase) | 1 | 1.31 (1.00 to 1.71) | 0.05 | 1.37 (1.04 to 1.79) | 0.03 | 1.20 (0.90 to 1.59) | 0.22

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.03, n = 207

    2 | 1.29 (1.00 to 1.67) | 0.05 | 1.35 (1.03 to 1.75) | 0.03 | 1.21 (0.91 to 1.61) | 0.19

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.53, n = 222

    PUFA:SFA ratio (per 1 unit increase) | 1 | 0.84 (0.39 to 1.80) | 0.66 | 0.78 (0.36 to 1.70) | 0.53 | 0.56 (0.27 to 1.18) | 0.13

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.03, n = 429

    PUFA:SFA ratio (per 1 unit increase) | 1 | 1.35 (1.01 to 1.80) | 0.04 | 1.39 (1.03 to 1.87) | 0.03 | 1.27 (0.93 to 1.73) | 0.14

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.99, n = 222

    2 | 1.05 (0.56 to 1.97) | 0.88 | 1.00 (0.52 to 1.93) | 0.99 | 0.77 (0.39 to 1.52) | 0.46

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.01, n = 429

    2 | 1.53 (1.14 to 2.05) | <0.01 | 1.58 (1.17 to 2.13) | <0.01 | 1.44 (1.04 to 1.98) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.65, n = 222

    SFA (per 5 en% increase) | 1 | 0.77 (0.48 to 1.24) | 0.28 | 0.89 (0.54 to 1.47) | 0.65 | 0.98 (0.58 to 1.65) | 0.93

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.18, n = 207

    SFA (per 5 en% increase) | 1 | 0.77 (0.52 to 1.13) | 0.18 | 0.77 (0.52 to 1.13) | 0.18 | 0.74 (0.50 to 1.11) | 0.15

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.06, n = 429

    SFA (per 5 en% increase) | 1 | 0.74 (0.57 to 0.97) | 0.03 | 0.77 (0.58 to 1.01) | 0.06 | 0.77 (0.58 to 1.03) | 0.08

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.54, n = 222

    2 | 0.76 (0.48 to 1.21) | 0.25 | 0.86 (0.53 to 1.39) | 0.54 | 0.95 (0.57 to 1.58) | 0.84

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.31, n = 207

    2 | 0.81 (0.56 to 1.19) | 0.29 | 0.82 (0.56 to 1.21) | 0.31 | 0.78 (0.52 to 1.16) | 0.22

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    decreases, p = 0.02, n = 429

    2 | 0.70 (0.53 to 0.91) | <0.01 | 0.72 (0.54 to 0.95) | 0.02 | 0.72 (0.54 to 0.97) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.75, n = 222

    PUFA (unspecified; per 5 en% increase) | 1 | 1.08 (0.71 to 1.66) | 0.71 | 1.07 (0.69 to 1.67) | 0.75 | 1.00 (0.62 to 1.61) | 0.99

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.01, n = 429

    PUFA (unspecified; per 5 en% increase) | 1 | 1.26 (1.04 to 1.52) | 0.02 | 1.29 (1.07 to 1.57) | <0.01 | 1.19 (0.97 to 1.47) | 0.09

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    no effect, p = 0.68, n = 222

    2 | 1.10 (0.73 to 1.65) | 0.65 | 1.09 (0.72 to 1.66) | 0.68 | 1.02(0.65 to 1.60) | 0.93

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular mortality

    increases, p = 0.01, n = 429

    2 | 1.31 (1.09 to 1.58) | <0.01 | 1.35 (1.12 to 1.63) | <0.01 | 1.26 (1.02 to 1.54) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Triglycerides

    no effect, p = 0.06

    Triglycerides (mg/dL; 1 mg/dL=0.011 mmol/L) | 185.9 (168.8 to 202.9) | 189.0 (162.6 to 215.4) | 151.8 (133.9 to 169.7) | 135.5 (126.0 to 145.1) | 0.06

    PMID 23386268 · one of two readings recorded this

  • all cause mortality (primary), cardiovascular mortality and coronary heart disease mortality, intention-to-treat Kaplan-Meier and Cox hazard ratios, Sydney Diet Heart Study

    increases, all cause mortality HR 1.62 (95% CI 1.00 to 2.64), 17.6% v 11.8%, p = 0.051

    Not recorded as a finding: the intervention held more than the compound

    Compared with the control group, the intervention group had an increased risk of all cause mortality (17.6% v 11.8%; hazard ratio 1.62 (95% confidence interval 1.00 to 2.64); P=0.051), cardiovascular mortality (17.2% v 11.0%; 1.70 (1.03 to 2.80); P=0.037), and mortality from coronary heart disease (16.3% v 10.1%; 1.74 (1.04 to 2.92); P=0.036) (fig 2).

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, alcohol light stratum

    no effect, p = 0.71, n = 71

    Light (<200 kcal/day) | 71 | 1.09 (0.69 to 1.72) | 0.71

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, alcohol light stratum

    increases, p = 0.05, n = 150

    Light (<200 kcal/day) | 150 | 1.43 (1.00 to 2.04) | 0.05

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, alcohol moderate/heavy stratum

    increases, p = 0.01, n = 79

    Moderate/heavy (>200 kcal/day) | 79 | 1.70 (1.18 to 2.46) | <0.01

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, alcohol moderate/heavy stratum

    increases, p = 0.01, n = 162

    Moderate/heavy (>200 kcal/day) | 162 | 1.66 (1.23 to 2.25) | <0.01

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, alcohol none stratum

    no effect, p = 0.25, n = 57

    None | 57 | 1.40 (0.79 to 2.50) | 0.25

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, alcohol none stratum

    no effect, p = 0.6, n = 117

    None | 117 | 0.91 (0.65 to 1.28) | 0.60

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, non-smokers

    no effect, p = 0.75, n = 60

    No | 60 | 1.08 (0.67 to 1.68) | 0.75

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, non-smokers

    no effect, p = 0.62, n = 128

    No | 128 | 1.08 (0.79 to 1.49) | 0.62

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, smokers

    increases, p = 0.01, n = 147

    Yes | 147 | 1.55 (1.12 to 2.12) | 0.01

    PMID 23386268 · one of two readings recorded this

  • Cardiovascular death, smokers

    increases, p = 0.01, n = 301

    Yes | 301 | 1.46 (1.15 to 1.86) | <0.01

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    increases, p = 0.036

    mortality from coronary heart disease (16.3% v 10.1%; 1.74 (1.04 to 2.92); P=0.036)

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.11, n = 207

    LA:SFA ratio (per 1 unit increase) | 1 | 1.51 (1.00 to 2.30) | 0.05 | 1.59 (1.04 to 2.43) | 0.03 | 1.44 (0.93 to 2.23) | 0.11

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.09, n = 207

    2 | 1.55 (1.01 to 2.36) | 0.04 | 1.62 (1.05 to 2.48) | 0.03 | 1.47 (0.94 to 2.29) | 0.09

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.22, n = 207

    PUFA (LA specific; per 5 en% increase) | 1 | 1.31 (1.00 to 1.71) | 0.05 | 1.37 (1.04 to 1.79) | 0.03 | 1.20 (0.90 to 1.59) | 0.22

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.19, n = 207

    2 | 1.29 (1.00 to 1.67) | 0.05 | 1.35 (1.03 to 1.75) | 0.03 | 1.21 (0.91 to 1.61) | 0.19

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.13, n = 222

    PUFA:SFA ratio (per 1 unit increase) | 1 | 0.84 (0.39 to 1.80) | 0.66 | 0.78 (0.36 to 1.70) | 0.53 | 0.56 (0.27 to 1.18) | 0.13

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.14, n = 429

    PUFA:SFA ratio (per 1 unit increase) | 1 | 1.35 (1.01 to 1.80) | 0.04 | 1.39 (1.03 to 1.87) | 0.03 | 1.27 (0.93 to 1.73) | 0.14

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.46, n = 222

    2 | 1.05 (0.56 to 1.97) | 0.88 | 1.00 (0.52 to 1.93) | 0.99 | 0.77 (0.39 to 1.52) | 0.46

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    increases, p = 0.03, n = 429

    2 | 1.53 (1.14 to 2.05) | <0.01 | 1.58 (1.17 to 2.13) | <0.01 | 1.44 (1.04 to 1.98) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.93, n = 222

    SFA (per 5 en% increase) | 1 | 0.77 (0.48 to 1.24) | 0.28 | 0.89 (0.54 to 1.47) | 0.65 | 0.98 (0.58 to 1.65) | 0.93

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.15, n = 207

    SFA (per 5 en% increase) | 1 | 0.77 (0.52 to 1.13) | 0.18 | 0.77 (0.52 to 1.13) | 0.18 | 0.74 (0.50 to 1.11) | 0.15

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.08, n = 429

    SFA (per 5 en% increase) | 1 | 0.74 (0.57 to 0.97) | 0.03 | 0.77 (0.58 to 1.01) | 0.06 | 0.77 (0.58 to 1.03) | 0.08

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.84, n = 222

    2 | 0.76 (0.48 to 1.21) | 0.25 | 0.86 (0.53 to 1.39) | 0.54 | 0.95 (0.57 to 1.58) | 0.84

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.22, n = 207

    2 | 0.81 (0.56 to 1.19) | 0.29 | 0.82 (0.56 to 1.21) | 0.31 | 0.78 (0.52 to 1.16) | 0.22

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    decreases, p = 0.03, n = 429

    2 | 0.70 (0.53 to 0.91) | <0.01 | 0.72 (0.54 to 0.95) | 0.02 | 0.72 (0.54 to 0.97) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.99, n = 222

    PUFA (unspecified; per 5 en% increase) | 1 | 1.08 (0.71 to 1.66) | 0.71 | 1.07 (0.69 to 1.67) | 0.75 | 1.00 (0.62 to 1.61) | 0.99

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.09, n = 429

    PUFA (unspecified; per 5 en% increase) | 1 | 1.26 (1.04 to 1.52) | 0.02 | 1.29 (1.07 to 1.57) | <0.01 | 1.19 (0.97 to 1.47) | 0.09

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    no effect, p = 0.93, n = 222

    2 | 1.10 (0.73 to 1.65) | 0.65 | 1.09 (0.72 to 1.66) | 0.68 | 1.02(0.65 to 1.60) | 0.93

    PMID 23386268 · one of two readings recorded this

  • Coronary heart disease mortality

    increases, p = 0.03, n = 429

    2 | 1.31 (1.09 to 1.58) | <0.01 | 1.35 (1.12 to 1.63) | <0.01 | 1.26 (1.02 to 1.54) | 0.03

    PMID 23386268 · one of two readings recorded this

  • Diastolic blood pressure

    no effect, p = 0.38

    Diastolic blood pressure (mm Hg) | 88.5 (86.9 to 90.0) | 88.5 (86.9 to 90.2) | 87.9 (86.0 to 89.9) | 87.5 (85.7 to 89.3) | 0.38

    PMID 23386268 · one of two readings recorded this

  • Dietary alcohol intake (median)

    no effect, p = 0.42

    Alcohol‡ | 2.3 (0.0-8.1) | 2.4 (0.0-8.9) | 4.0 (0.9-8.7) | +1.7 | 3.1 (0.7-8.9) | +0.7 | 0.42

    PMID 23386268 · one of two readings recorded this

  • Dietary carbohydrate intake (median)

    no effect, p = 0.31

    Carbohydrate‡ | 40.5 (37.0-45.2) | 39.9 (35.2-46.1) | 40.6 (35.6-44.8) | +0.1 | 41.3 (36.1-46.3) | +1.4 | 0.31

    PMID 23386268 · one of two readings recorded this

  • Dietary cholesterol intake (median)

    decreases, p = 0.001

    Cholesterol (mg/day) | 439 (344-593) | 477 (355-621) | 331 (269-408) | −108 | 238 (203-283) | −239 | <0.001

    PMID 23386268 · one of two readings recorded this

  • Dietary energy intake (median)

    no effect, p = 0.07

    Energy (kcal/day; 1 kcal=4.18 kJ) | 2384 (2072-2770) | 2423 (1972-2860) | 2194 (1804-2524) | −190 | 2256 (1958-2574) | −167 | 0.07

    PMID 23386268 · one of two readings recorded this

  • Dietary MUFA intake (median)

    decreases, p = 0.001

    MUFA‡ | 14.7 (12.8-16.9) | 14.6 (13.2-16.5) | 14.0 (12.3-15.2) | −0.7 | 11.2 (10.1-12.7) | −3.4 | <0.001

    PMID 23386268 · one of two readings recorded this

  • Dietary protein intake (median)

    no effect, p = 0.25

    Protein‡ | 14.1 (12.4-16.3) | 14.4 (12.6-16.5) | 15.3 (13.4-17.3) | +1.2 | 14.8 (13.4-16.8) | +0.4 | 0.25

    PMID 23386268 · one of two readings recorded this

  • Dietary PUFA intake (median)

    increases, p = 0.001

    PUFA‡ | 6.2 (3.2-9.2) | 6.1 (3.0-9.2) | 8.4 (6.7-10.9) | +2.2 | 15.4 (12.3-17.9) | +9.3§ | <0.001

    PMID 23386268 · one of two readings recorded this

  • Dietary PUFA:SFA ratio (median)

    increases, p = 0.001

    PUFA:SFA ratio | 0.41 (0.18-0.68) | 0.38 (0.16-0.65) | 0.63 (0.45-0.92) | +0.22 | 1.72 (1.31-2.08) | +1.34 | <0.001

    PMID 23386268 · one of two readings recorded this

  • Dietary SFA intake (median)

    decreases, p = 0.001

    SFA‡ | 15.6 (13.0-18.7) | 16.2 (13.4-19.3) | 13.5 (11.4-15.6) | −2.1 | 9.3 (8.2-10.9) | −6.9 | <0.001

    PMID 23386268 · one of two readings recorded this

  • Dietary total fat intake (median)

    no effect, p = 0.87

    Total fat‡ | 39.2 (35.0-43.5) | 40.2 (36.6-43.4) | 38.1 (34.3-41.2) | −1.1 | 38.3 (36.1-46.3) | −1.9 | 0.87

    PMID 23386268 · one of two readings recorded this

  • mortality from coronary heart disease, hazard ratio intervention versus control

    increases, 16.3% v 10.1%; 1.74 (1.04 to 2.92), p = 0.036

    Not recorded as a finding: The list has no CHD-death node; the same sentence carries the all-cause and cardiovascular figures that were extracted

    Compared with the control group, the intervention group had an increased risk of all cause mortality (17.6% v 11.8%; hazard ratio 1.62 (95% confidence interval 1.00 to 2.64); P=0.051), cardiovascular mortality (17.2% v 11.0%; 1.70 (1.03 to 2.80); P=0.037), and mortality from coronary heart disease (16.3% v 10.1%; 1.74 (1.04 to 2.92); P=0.036) (fig 2).

    PMID 23386268 · one of two readings recorded this

  • Serum total cholesterol, percent change

    decreases, p = 0.001

    Serum total cholesterol decreased more in the LA intervention group than in the control group (−13.3% v −5.5%; P<0.001)

    PMID 23386268 · one of two readings recorded this

  • Systolic blood pressure

    no effect, p = 0.49

    Systolic blood pressure (mm Hg) | 136.9 (134.2 to 139.6) | 136.6 (133.9 to 139.3) | 136.5 (133.4 to 139.5) | 136.4 (133.8 to 139.0) | 0.49

    PMID 23386268 · one of two readings recorded this

  • Total cholesterol

    decreases, p = 0.001

    Total cholesterol (mg/dL; 1 mg/dL=0.026 mmol/L) | 282.0 (274.8 to 289.1) | 281.3 (272.9 to 289.7) | 266.5 (259.1 to 273.8) | 243.9 (237.4 to 250.4) | <0.001

    PMID 23386268 · one of two readings recorded this

  • triglycerides, BMI and systolic and diastolic blood pressure between arms

    no effect, no significant differences between groups at baseline or follow-up

    Not recorded as a finding: Sentence names no compound or arm (agentless), so it does not support a claim on its own

    There were no significant differences between groups in triglycerides, body mass index, or systolic or diastolic blood pressure at baseline or during follow-up.

    PMID 23386268 · one of two readings recorded this

  • CHD deaths, dose-response per 5% of energy from LA

    decreases

    a 13% lower risk of CHD deaths (RR, 0.87; 95% CI, 0.81–0.93; Figure 7)

    PMID 25161045 · one of two readings recorded this

  • CHD deaths, highest vs lowest category of dietary LA intake

    decreases

    The fixed-effect summary of RR for comparing the highest with lowest category was 0.79 (95% CI, 0.71–0.89; Figure 3)

    PMID 25161045 · one of two readings recorded this

  • CHD deaths, substituting 5% energy from LA for carbohydrates

    decreases

    an 13% lower risk of CHD deaths (RR, 0.87; 95% CI, 0.81–0.94; Supplemental Figure S3)

    PMID 25161045 · one of two readings recorded this

  • CHD deaths, substituting 5% energy from LA for saturated fat

    decreases

    an 13% lower risk of CHD deaths when substituting for the same amount of energy from SFAs (RR, 0.87; 95% CI, 0.82–0.94; Supplemental Figure S4)

    PMID 25161045 · one of two readings recorded this

  • CHD events, dose-response per 5% of energy from LA

    decreases

    An increment of 5% of energy intake from LA was associated with a 10% lower risk of CHD events (RR, 0.90; 95% CI, 0.85–0.94; I2 = 44.6%; Figure 6)

    PMID 25161045 · one of two readings recorded this

  • CHD events, substituting 5% energy from LA for carbohydrates

    decreases

    the risk estimate for substituting 5% energy intake from LA for carbohydrates was 0.90 (95% CI, 0.85–0.94; I2 = 47.3%; Supplemental Figure S1) with a fixed-effect model

    PMID 25161045 · one of two readings recorded this

  • CHD events, substituting 5% energy from LA for carbohydrates

    decreases

    and 0.89 (95% CI, 0.80–0.98) with a random-effects model

    PMID 25161045 · one of two readings recorded this

  • CHD events, substituting 5% energy from LA for saturated fat

    decreases

    the risk estimate for substituting 5% energy intake from LA for SFAs was 0.91 (95% CI, 0.87–0.96; I2 = 55.9%; Supplemental Figure S2) with a fixed-effect model

    PMID 25161045 · one of two readings recorded this

  • CHD events, substituting 5% energy from LA for saturated fat

    no effect

    and 0.90 (95% CI, 0.80–1.01) with a random-effects model

    PMID 25161045 · one of two readings recorded this

  • coronary heart disease deaths, pooled RR highest versus lowest dietary LA intake

    decreases

    Not recorded as a finding: Node requires incident CHD events; CHD death alone is a narrower endpoint and no node matches (cardiovascular mortality requires CVD as underlying cause).

    Among 11 cohort studies (12 estimates) that examined the association between LA and CHD deaths, higher LA intake was associated with a lower risk of CHD deaths.

    PMID 25161045 · both readings recorded this

  • Non-linearity test of LA intake and CHD deaths

    no effect, p = 0.72

    CHD deaths (P=0.72 for non-linearity; Figure 5)

    PMID 25161045 · one of two readings recorded this

  • Non-linearity test of LA intake and CHD events

    no effect, p = 0.91

    we found a linear association between LA intake and CHD events (P=0.91 for non-linearity; Figure 4)

    PMID 25161045 · one of two readings recorded this

  • Publication bias (Begg's test), CHD deaths

    no effect, p = 1

    Begg's test suggested no evidence of publication bias for either CHD events (P = 0.25) or CHD deaths (P = 1.00)

    PMID 25161045 · one of two readings recorded this

  • Publication bias (Begg's test), CHD events

    no effect, p = 0.25

    Begg's test suggested no evidence of publication bias for either CHD events (P = 0.25) or CHD deaths (P = 1.00)

    PMID 25161045 · one of two readings recorded this

  • Total CHD events, highest vs lowest category of dietary LA intake

    decreases

    The fixed-effect summary of RR for comparing the highest with lowest category was 0.85 (95% CI, 0.78–0.92; Figure 2) with medium heterogeneity (I2 = 35.5%)

    PMID 25161045 · one of two readings recorded this

  • Total CHD events, highest vs lowest category of dietary LA intake

    decreases

    This finding was similar using a random-effects model (RR, 0.86; 95% CI, 0.76–0.97)

    PMID 25161045 · one of two readings recorded this

  • HDL cholesterol

    no effect, p = 0.468

    a non-significant decrease in HDL cholesterol (mean difference = -0.051; 95% CI -0.188, 0.086; P = 0.468)

    PMID 25379623 · one of two readings recorded this

  • HDL cholesterol

    no effect, p = 0.455

    non-significantly increased HDL-C (mean difference = 0.075; 95% CI -0.121, 0.270; P=0.455)

    PMID 25379623 · one of two readings recorded this

  • LDL cholesterol

    decreases, p = 0.002

    a significant decrease in LDL cholesterol (mean difference = -0.218; 95% CI -0.358, -0.077; P = 0.002)

    PMID 25379623 · one of two readings recorded this

  • LDL cholesterol

    decreases, p = 0.028

    significantly decreased LDL cholesterol (mean difference = -0.231; 95% CI -0.438, -0.024; P = 0.028)

    PMID 25379623 · one of two readings recorded this

  • Total cholesterol

    no effect, p = 0.896

    a non-significant increase in total cholesterol (mean difference = 0.009; 95% CI -0.128, 0.146; P = 0.896)

    PMID 25379623 · one of two readings recorded this

  • Total cholesterol

    no effect, p = 0.124

    non-significantly decreased total cholesterol (mean difference = -0.158; 95% CI -0.349, 0.042; P = 0.124)

    PMID 25379623 · one of two readings recorded this

  • Triacylglycerol (TAG)

    no effect, p = 0.344

    a non-significant decrease in TAG (mean difference = -0.065; 95% CI -0.20, 0.07; P = 0.344)

    PMID 25379623 · one of two readings recorded this

  • Triacylglycerol (TAG)

    no effect, p = 0.433

    non-significantly decreased TAG (mean difference = -0.078; 95% CI -0.274, 0.117; P = 0.433)

    PMID 25379623 · one of two readings recorded this

  • Diastolic blood pressure, pooled net change

    no effect, p = 0.52

    the pooled estimate of change in DBP was 0.69 mm Hg (95% CI: −1.41, 2.80; P = 0.52)

    PMID 25889408 · one of two readings recorded this

  • Heterogeneity I2, diastolic BP meta-analysis

    p = 0.03

    with substantial heterogeneity across trials (I2 = 52.0%, P = 0.03)

    PMID 25889408 · one of two readings recorded this

  • Heterogeneity I2, systolic BP meta-analysis

    p = 0.25

    without significant heterogeneity (I2 = 22.2%, P = 0.25)

    PMID 25889408 · one of two readings recorded this

  • Meta-regression of DBP net change on baseline BP

    no effect, p = 0.13

    Baseline BP | −0.11 (−0.53, 0.30) | 0.54 | −0.23 (−0.61, 0.14) | 0.13

    PMID 25889408 · one of two readings recorded this

  • Meta-regression of DBP net change on CLA dose

    no effect, p = 0.14

    Dose | −1.78 (−3.76, 0.20) | 0.07 | −1.32 (−3.20, 0.56) | 0.14

    PMID 25889408 · one of two readings recorded this

  • Meta-regression of DBP net change on intervention duration

    no effect, p = 0.32

    Duration | −0.16 (−0.53, 0.20) | 0.32 | −0.19 (−0.61, 0.23) | 0.32

    PMID 25889408 · one of two readings recorded this

  • Meta-regression of SBP net change on baseline BP

    no effect, p = 0.54

    Baseline BP | −0.11 (−0.53, 0.30) | 0.54 | −0.23 (−0.61, 0.14) | 0.13

    PMID 25889408 · one of two readings recorded this

  • Meta-regression of SBP net change on CLA dose

    no effect, p = 0.07

    Dose | −1.78 (−3.76, 0.20) | 0.07 | −1.32 (−3.20, 0.56) | 0.14

    PMID 25889408 · one of two readings recorded this

  • Meta-regression of SBP net change on intervention duration

    no effect, p = 0.32

    Duration | −0.16 (−0.53, 0.20) | 0.32 | −0.19 (−0.61, 0.23) | 0.32

    PMID 25889408 · one of two readings recorded this

  • Sensitivity analysis, SBP pooled change, leave-one-out lower bound

    no effect

    yielded a range from 0.22 mm Hg (95% CI: −1.45, 1.90) to–0.27 mm Hg (95% CI:-2.83, 2.29)

    PMID 25889408 · one of two readings recorded this

  • Sensitivity analysis, SBP pooled change, leave-one-out upper bound

    no effect

    yielded a range from 0.22 mm Hg (95% CI: −1.45, 1.90) to–0.27 mm Hg (95% CI:-2.83, 2.29)

    PMID 25889408 · one of two readings recorded this

  • Systolic blood pressure, pooled net change

    no effect, p = 0.98

    The pooled estimate of change in SBP was −0.03 mm Hg (95% CI: −2.29, 2.24; P = 0.98)

    PMID 25889408 · one of two readings recorded this

  • breast cancer risk, pooled relative risk for highest versus lowest level of dietary and serum linoleic acid in prospective cohort and nested case-control studies

    pooled RR 0.98 (0.93, 1.04), highest versus lowest level

    Not recorded as a finding: the direction is carried only as a signed number

    Compared with the lowest level of linoleic acid, the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid.

    PMID 26434699 · one of two readings recorded this

  • breast cancer risk, pooled relative risk highest versus lowest level of dietary and serum linoleic acid

    pooled RR 0.98 (0.93, 1.04) highest versus lowest linoleic acid

    Not recorded as a finding: a direction is stated and the estimate does not support it

    Compared with the lowest level of linoleic acid, the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid.

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The RR (95 % CI) of breast cancer was 0·97 (0·91, 1·04), 0·95 (0·85, 1·07), 0·96 (0·86, 1·07), 0·98 (0·87, 1·10) and 0·99 (0·85, 1·14) for linoleic acid intake of 5, 10, 15, 20 and 25 g/d, respectively

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The risk of breast cancer decreased by 1 % (RR=0·99; 95 % CI 0·93, 1·05) for every 10 g/d increment in linoleic acid intake

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The pooled RR (95 % CI) for dietary and serum linoleic acid were 0·99 (0·92, 1·06) and 0·98 (0·88, 1·08), respectively

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    the pooled relative risk (RR; 95 % CI) of breast cancer was 0·98 (0·93, 1·04) for the highest level of linoleic acid

    PMID 26434699 · one of two readings recorded this

  • Breast cancer risk

    no effect

    The pooled RR (95 % CI) for dietary and serum linoleic acid were 0·99 (0·92, 1·06) and 0·98 (0·88, 1·08), respectively

    PMID 26434699 · one of two readings recorded this

  • alpha-Linolenic acid concentration

    increases

    68 (95 % CI 53, 84) % for ALA

    PMID 26878105 · one of two readings recorded this

  • alpha-Linolenic acid concentration

    increases

    ALA (cis-9,12,15-18: 3) | 3·05 | 2·08, 4·02 | Large | Medium | High | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • alpha-Tocopherol concentration

    increases

    The MPD was 13 (95 % CI 1, 26) %

    PMID 26878105 · one of two readings recorded this

  • alpha-Tocopherol concentration

    increases

    α-Tocopherol | 0·74 | 0·01, 1·47 | Moderate | Medium | Moderate | Medium | Low

    PMID 26878105 · one of two readings recorded this

  • Arachidonic acid concentration

    decreases

    AA (cis-5,8,11,14-20: 4) | −0·98 | −1·95, 0 | Moderate | Medium | Poor | Strong | Very low

    PMID 26878105 · one of two readings recorded this

  • beta-Carotene concentration

    no effect

    β-Carotene | 0·08 | −0·51, 0·67 | Small | Low | Moderate | No | Moderate

    PMID 26878105 · one of two readings recorded this

  • Carotenoids concentration

    no effect

    Carotenoids | 0·69 | −0·73, 2·1 | Moderate | High | Poor | No | Low

    PMID 26878105 · one of two readings recorded this

  • CLA10 (trans-10, cis-12-18:2) concentration

    no effect

    CLA10 (trans-10- cis-12-18: 2) | 1·20 | −1·03, 3·43 | Large | Medium | Poor | Medium | Low

    PMID 26878105 · one of two readings recorded this

  • CLA9 (cis-9, trans-11-18:2) concentration

    increases

    24 (95 % CI 8, 39) % for CLA9

    PMID 26878105 · one of two readings recorded this

  • CLA9 (cis-9, trans-11-18:2) concentration

    increases

    CLA9 (cis-9- trans-11-18: 2) | 1·22 | 0·5, 1·95 | Large | Low | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • DHA concentration

    no effect

    % for DPA and 21 (95 % CI −3, 47) % for DHA

    PMID 26878105 · one of two readings recorded this

  • DHA concentration

    no effect

    DHA (cis-4,7,10,13,16,19-22: 6) | 0·21 | −0·26, 0·68 | Small | Low | High | No | Moderate

    PMID 26878105 · one of two readings recorded this

  • DPA concentration

    increases

    45 (95 % CI 18, 71)

    PMID 26878105 · one of two readings recorded this

  • DPA concentration

    increases

    DPA (cis-7,10,13,16,19-22: 5) | 1·24 | 0·37, 2·12 | Large | Low | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • EPA concentration

    increases

    67 (95 % CI 32, 102) % for EPA

    PMID 26878105 · one of two readings recorded this

  • EPA concentration

    increases

    EPA (cis-5,8,11,14,17-20: 5) | 1·31 | 0·56, 2·06 | Large | Medium | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • Iodine concentration

    decreases

    −74 (95 % CI −115, −33)

    PMID 26878105 · one of two readings recorded this

  • Iodine concentration

    decreases

    I | −1·20 | −1·8, −0·59 | Large | Low | Moderate | No | High

    PMID 26878105 · one of two readings recorded this

  • Iron concentration

    increases

    20 (95 % CI 0, 41) % for Fe

    PMID 26878105 · one of two readings recorded this

  • Iron concentration

    increases

    Fe | 0·37 | 0·03, 0·71 | Moderate | Low | High | No | High

    PMID 26878105 · one of two readings recorded this

  • Lauric acid (12:0) concentration

    no effect

    12: 0 (lauric acid) | 0·18 | −1·39, 1·75 | Small | High | Poor | Medium | Very low

    PMID 26878105 · one of two readings recorded this

  • Linoleic acid (cis-9,12-18:2) concentration

    no effect

    LA (cis-9,12-18: 2) | −0·92 | −1·96, 0·11 | Moderate | Medium | Poor | Medium | Low

    PMID 26878105 · one of two readings recorded this

  • Lutein concentration

    no effect

    Lutein | 0·85 | −0·98, 2·68 | Large | Medium | Poor | No | Moderate

    PMID 26878105 · one of two readings recorded this

  • Milk yield per cow

    decreases

    significantly lower in organic (−23; 95 % CI −31, −15 %) compared with conventional

    PMID 26878105 · one of two readings recorded this

  • Milk yield

    decreases

    Milk yield | −1·23 | −1·64, −0·81 | Large | Medium | High | No | High

    PMID 26878105 · one of two readings recorded this

  • Myristic acid (14:0) concentration

    no effect

    14: 0 (myristic acid) | 0·32 | −0·42, 1·05 | Small | High | Moderate | Medium | Very low

    PMID 26878105 · one of two readings recorded this

  • n-3:n-6 ratio

    increases

    n-3: n-6 Ratio | 1·50 | 0·81, 2·19 | Large | Low | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • n-6:n-3 ratio

    decreases

    n-6: n-3 Ratio | −2·26 | −4·34, −0·18 | Large | High | Poor | Medium | Low

    PMID 26878105 · one of two readings recorded this

  • Oleic acid (cis-9-18:1) concentration

    no effect

    OA (cis-9-18: 1) | 0·28 | −0·64, 1·2 | Small | Low | Poor | Medium | Low

    PMID 26878105 · one of two readings recorded this

  • Palmitic acid (16:0) concentration

    no effect

    16: 0 (palmitic acid) | −0·50 | −1·17, 0·17 | Moderate | Medium | Moderate | Strong | Low

    PMID 26878105 · one of two readings recorded this

  • Selenium concentration

    decreases

    % for I and −21 (95 % CI −49, 6) % for Se

    PMID 26878105 · one of two readings recorded this

  • Selenium concentration

    decreases

    Se | −0·49 | −0·89, −0·1 | Moderate | Low | High | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • Somatic cell count

    no effect

    SCC | 0·20 | −0·43, 0·82 | Small | Medium | Moderate | Medium | Low

    PMID 26878105 · one of two readings recorded this

  • Total CLA concentration

    increases

    The MPD were 41 (95 % CI 14, 68) % for total CLA

    PMID 26878105 · one of two readings recorded this

  • Total CLA concentration

    increases

    CLA (total) | 1·40 | 0·37, 2·42 | Large | Medium | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • Total MUFA concentration

    no effect

    MUFA | 0·18 | −0·4, 0·76 | Small | Medium | Moderate | Strong | Very low

    PMID 26878105 · one of two readings recorded this

  • Total n-3 FA concentration

    increases

    n-3 FA | 2·18 | 1·11, 3·25 | Large | Low | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • Total n-3 PUFA concentration

    increases

    The MPD was 56 (95 % CI 38, 74) % for total n-3

    PMID 26878105 · one of two readings recorded this

  • Total n-6 FA concentration

    no effect

    n-6 FA | −0·06 | −0·97, 0·86 | Small | High | Moderate | Medium | Very low

    PMID 26878105 · one of two readings recorded this

  • Total PUFA concentration

    increases

    with an MPD of 7·3 (95 % CI −0·7, 15) %

    PMID 26878105 · one of two readings recorded this

  • Total PUFA concentration

    increases

    PUFA | 0·88 | 0·19, 1·56 | Large | Medium | Moderate | No | Moderate

    PMID 26878105 · one of two readings recorded this

  • Total SFA concentration

    no effect

    SFA | −0·17 | −0·66, 0·31 | Small | Medium | High | Strong | Low

    PMID 26878105 · one of two readings recorded this

  • Total VLC n-3 PUFA (EPA+DPA+DHA) concentration

    increases

    an MPD of 57 (95 % CI 27, 87) %

    PMID 26878105 · one of two readings recorded this

  • Urea concentration

    no effect

    Urea | −0·42 | −1·04, 0·19 | Moderate | Low | Moderate | No | Moderate

    PMID 26878105 · one of two readings recorded this

  • Vaccenic acid concentration

    increases

    66 (95 % CI 20, 112)

    PMID 26878105 · one of two readings recorded this

  • Vaccenic acid (trans-11-18:1) concentration

    increases

    VA (trans-11-18: 1) | 2·48 | 1·08, 3·87 | Large | Medium | Moderate | Medium | Moderate

    PMID 26878105 · one of two readings recorded this

  • Cancer mortality

    decreases

    0.89 (95% CI: 0.85, 0.93; I2 = 0%) for cancer mortality

    PMID 32020162 · one of two readings recorded this

  • Cancer mortality

    decreases

    0.91 (95% CI: 0.84, 0.98; I2 = 26.3%) for cancer mortality

    PMID 32020162 · one of two readings recorded this

  • Cardiovascular disease mortality

    decreases

    0.87 (95% CI: 0.82, 0.92; I2 = 3.7%) for CVD mortality

    PMID 32020162 · one of two readings recorded this

  • Cardiovascular disease mortality

    decreases

    0.89 (95% CI: 0.85, 0.94; I2 = 28.9%) for CVD mortality

    PMID 32020162 · one of two readings recorded this

  • Total mortality

    decreases

    Pooled RRs comparing extreme categories of dietary LA intake (high vs low) were 0.87 (95% CI: 0.81, 0.94; I2 = 67.9%) for total mortality

    PMID 32020162 · one of two readings recorded this

  • Total mortality

    decreases

    Pooled RRs for each SD increment in LA concentrations in adipose tissue/blood compartments were 0.91 (95% CI: 0.87, 0.95; I2 = 64.1%) for total mortality

    PMID 32020162 · one of two readings recorded this

  • TNF-alpha

    decreases, p = 0.011

    found a significant reduction in TNF-α compared to placebo [(WMD = −0.99 mg/dl; 95% CI, −1.76 to −0.22; p = 0.011

    PMID 36911696 · one of two readings recorded this

  • TNF-alpha

    decreases, p = 0.001

    intervention dose of <3 (g/day) (WMD = −3.08 mg/dl; 95% CI, −4.91 to −1.25; p = 0.001)

    PMID 36911696 · one of two readings recorded this

  • TNF-alpha

    decreases, p = 0.002

    healthy people (WMD = −2.01 mg/dl; 95% CI, −3.31 to −0.71; p = 0.002)

    PMID 36911696 · one of two readings recorded this

  • TNF-alpha

    decreases, p = 0.033

    male subjects (WMD = −1.01 mg/dl; 95% CI, −1.95 to −0.08; p = 0.033)

    PMID 36911696 · one of two readings recorded this

  • TNF-alpha

    decreases, p = 0.002

    when a mixture of two isomers was used (WMD = −1.41 mg/dl; 95% CI, −2.31 to −0.50; p = 0.002)

    PMID 36911696 · one of two readings recorded this

  • TNF-alpha

    decreases, p = 0.048

    subjects with normal range of BMI (18.5–24.9) (WMD = −9.29 mg/dl; 95% CI, −18.51 to −0.08; p = 0.048)

    PMID 36911696 · one of two readings recorded this

  • TNF-alpha

    increases, p = 0.001

    TNF-α was significantly increased (WMD = 1.29 mg/dl; 95% CI, 0.64 to 1.93; p < 0.001)

    PMID 36911696 · one of two readings recorded this

  • Adiponectin publication bias (Begg's test)

    no effect, p = 0.198

    no significant publication bias was detected according to Begg’s test for most of the variables, such as CRP (p = 0.189), IL-6 (p = 0.441), adiponectin (p = 0.198), and leptin (p = 0.050)

    PMID 36911696 · one of two readings recorded this

  • Adiponectin

    no effect, p = 0.976

    CLA supplementation had no significant effect on adiponectin level in the intervention group compared to placebo [(WMD = −0.01 mg/dl; 95% CI, −0.68 to 0.71; p = 0.976

    PMID 36911696 · one of two readings recorded this

  • Adiponectin

    decreases, p = 0.001

    a significant decrease in adiponectin levels in the female subjects (WMD = −1.05 mg/dl; 95% CI, −1.58 to −0.52; p < 0.001)

    PMID 36911696 · one of two readings recorded this

  • C-reactive protein

    increases, p = 0.048

    significantly increased CRP compared to placebo [(WMD = 0.26 mg/dl; 95% CI, 0.00 to 0.52; p = 0.048

    PMID 36911696 · one of two readings recorded this

  • C-reactive protein

    increases, p = 0.017

    supplementation dose ≥3 (g/day) (WMD = 0.49 mg/dl; 95% CI, 0.09 to 0.90; p = 0.017)

    PMID 36911696 · one of two readings recorded this

  • C-reactive protein

    increases, p = 0.016

    The effect of CLA on CRP was significant in studies with baseline CRP less than 3 mg/dl (WMD = 0.31 mg/dl; 95% CI, 0.05 to 0.57; p = 0.016)

    PMID 36911696 · one of two readings recorded this

  • C-reactive protein

    increases, p = 0.008

    and healthy subgroup (WMD = 0.39 mg/dl; 95% CI, 0.10 to 0.68; p = 0.008)

    PMID 36911696 · one of two readings recorded this

  • CRP publication bias (Begg's test)

    no effect, p = 0.189

    no significant publication bias was detected according to Begg’s test for most of the variables, such as CRP (p = 0.189), IL-6 (p = 0.441), adiponectin (p = 0.198), and leptin (p = 0.050)

    PMID 36911696 · one of two readings recorded this

The whole record — 299 rows